Leukemia patients who failed stopping meds may get another shot at drug-free remission
Disease control
Recruiting now
This study tests whether adding asciminib to standard tyrosine kinase inhibitors (TKIs) can help people with chronic myeloid leukemia (CML) safely stop all medication and remain in remission. It includes 69 adults who have been on TKIs for at least 5 years but previously failed t…
Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC